Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review

Overview of attention for article published in Cochrane database of systematic reviews, July 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 24 news outlets
blogs: 3 blogs
twitter: 259 tweeters

facebook: 7 Facebook pages
wikipedia: 4 Wikipedia pages

Citations

dimensions_citation: 163 Dimensions

Readers on

mendeley: 319 Mendeley

Summary News Blogs Twitter Facebook Wikipedia Dimensions citations

So far, Dimensions has found 163 publications that cite this research output.

163

The most recent citing publications are shown below. View all 163 publications that cite this research output on Dimensions.

Remdesivir for the treatment of COVID‐19

Article in Cochrane Database of Systematic Reviews (January 2023)

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

Article in Nature Cancer (December 2022)

One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients

Article in Journal of Clinical Investigation (December 2022)